- Report
- August 2023
- 80 Pages
Poland
From €2510EUR$2,595USD£2,125GBP
- Report
- August 2023
- 80 Pages
Japan
From €2510EUR$2,595USD£2,125GBP
- Report
- August 2023
- 80 Pages
Ireland
From €2510EUR$2,595USD£2,125GBP
- Report
- August 2023
- 80 Pages
Brazil
From €2510EUR$2,595USD£2,125GBP
- Report
- August 2023
- 80 Pages
Argentina
From €2510EUR$2,595USD£2,125GBP
- Report
- August 2023
- 100 Pages
Africa
From €3670EUR$3,795USD£3,108GBP
- Report
- February 2024
- 132 Pages
Global
From €919EUR$950USD£778GBP
- Report
- February 2024
- 132 Pages
Global
From €919EUR$950USD£778GBP
- Report
- August 2019
- 35 Pages
Global
- Report
- November 2021
- 545 Pages
Global
From €3868EUR$4,000USD£3,276GBP
- Report
- November 2021
- 233 Pages
Global
From €2418EUR$2,500USD£2,047GBP
- Report
- November 2021
- 1165 Pages
Global
From €5802EUR$6,000USD£4,914GBP
- Report
- March 2020
- 112 Pages
Global
From €4158EUR$4,300USD£3,522GBP
- Report
- March 2020
- 102 Pages
Global
From €4352EUR$4,500USD£3,685GBP
- Report
- February 2024
- 183 Pages
Global
From €3481EUR$3,600USD£2,948GBP
- Report
- February 2024
- 186 Pages
Global
From €3481EUR$3,600USD£2,948GBP
- Report
- February 2024
- 198 Pages
Global
From €3481EUR$3,600USD£2,948GBP
- Report
- February 2024
- 206 Pages
Global
From €3481EUR$3,600USD£2,948GBP
- Report
- February 2024
- 225 Pages
Global
From €3481EUR$3,600USD£2,948GBP
- Report
- September 2019
Global
From €5193EUR$5,370USD£4,398GBP
The genotyping market is a subset of the genomics industry that focuses on the identification of genetic variations between individuals. It is used to identify genetic markers associated with diseases, to determine the risk of developing certain conditions, and to identify the most effective treatments for a given individual. Genotyping is also used in the development of personalized medicine, which is tailored to the individual’s genetic makeup. Genotyping technologies include next-generation sequencing, microarrays, and PCR-based methods.
The genotyping market is expected to grow due to the increasing demand for personalized medicine, the development of new technologies, and the increasing availability of genomic data. Additionally, the increasing prevalence of chronic diseases and the need for more accurate diagnosis and treatment are expected to drive the growth of the genotyping market.
Some companies in the genotyping market include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and PerkinElmer. Show Less Read more